Trade Agreements and Health

 

 

Patent and Public Health:

Addressing the Future Imperatives of Health Security in the Post-TRIPS Era

11 April 2005, New Delhi

Full Report

As per obligations under the Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS) of the World Trade Organisation (WTO), from 1st January 2005 onwards the product patent regime has been introduced in India vide the Patent (Amendment) Act, 2005. Now product patent is enforced in all sectors, including the pharmaceutical and agro-chemical sectors, which so far had been out of such provisions. From the perspective of access to health, the questions that arise are: Is India prepared to deal with the changed situation? What should be the future course of action with respect to manufacture, trade and procurement of generic drugs?

There are law and policy tools that are available with the Government to deal with adverse situation vis-ΰ-vis access to medicines, which may arise due to the introduction of product patent regime. These include, among other things, built-in safeguards in the Patents Act using the TRIPS flexibilities, competition law and policy and drug price control regime. The questions that need to be looked into are: How to implement these built-in safeguards; How India should use competition law and policy to tackle adverse conditions with respect to access to drugs which may arise due to introduction of product patent regime? Does the new competition regime have such a scope? Is the present drug price control regime effective and sufficient in controlling the prices of patented drugs? etc.

The Workshop aims to discuss the above-said issues amongst the stakeholders and come out with suggestions that can shape an action plan to address future challenges with respect to access to health, in the post-TRIPS era

 

Agenda 

09.30 – 10.00 hrs

Registration

 

Inaugural Session

10.00 – 10.05 hrs

Welcome address by Shri B. P. Sharma, Joint Secretary, Department of Health, Ministry of Health & Family Welfare

10.05 – 10.20 hrs

Inaugural Address by Shri P. Hota, Secretary, Department of Health, Ministry of Health & Family Welfare

10.20 – 10.30 hrs

Address by Dr. S. J. Habayeb, WHO Representative to IndiaAddress by Dr. S. J. Habayeb, WHO Representative to India

10.30 – 10.35 hrs

Vote of thanks by Shri Rajesh Bhushan, Director (IH), Department of Health, Ministry of Health & Family Welfare

 

 

 

 

Introductory Session

An overview of recent law/policy developments on patents & public health

WTO Cell, Ministry of Health & Family Welfare

11.00 – 11.30 hrs

Tea Break

 

Technical Session I

11.30 – 11.45 hrs

Manufacture of ‘quality’ generic drugs – options available with Indian pharmaceutical sector and the preparedness of the Indian pharmaceutical industry to deal with the changed scenario

Shri Gajanan Wakankar, Executive Director, Indian Drug Manufacturers Association, Mumbai

11.45 – 12.00 hrs

Para 6 of Doha Declaration and India’s response

Shri Narendra B. Zaveri, Advocate, Mumbai

12.00 – 13.00 hrs

Open Discussion

 

13.00 – 14.00 hrs

Lunch Break

 

 

Technical Session II

14.00 – 14.15 hrs

How far the TRIPS-Flexibilities are being addressed in the Patent (Amendment) Act, 2005?

Shri B. K. Keayla, Centre for Study of Global Trade System and Development, New Delhi

14.15 – 14.30 hrs

Anti-competitive practices in Patent Licensing Arrangements and the scope of competition law/policy in dealing with them

Shri Anand Grover, AMTC, Mumbai

14.30 – 14.45 hrs

WHO perspective on Patents and Public Health

Dr. Weerasuriya, Regional Adviser, EDM, WHO-SEARO

14.45 – 15.30 hrs

Open Discussion

 

 

 

 

15.30 – 16.00 hrs

Tea Break

 

 

 

 

 

Concluding Session - The Way Forward

16.00 – 16.45 hrs

Post-TRIPS scenario and Access to Medicines: the way forward for India

·      Shri Z.H. Charna, Director, Organisation of Pharmaceutical Producers of India

·      Shri Ashwini Kumar, Drug Controller General of India, New Delhi

·      Shri Gurdeep Singh, Director, Department of Chemicals and Petrochemicals, New Delhi

·      Shri Sunil Nandraj, WRI Office

16.45 – 17.15 hrs

Open Discussions

17.15 – 17.30 hrs

Valedictory & vote of thanks

 

 

 

 

 

 

 

| | | | | |